Anticoagulant antidotes comprising antibodies that bind dabigatran and/or related compounds

An isolated antibody molecule of capable of binding to and neutralizing the activity of dabigatran, which comprises a heavy chain variable domain with a CDR1 selected from the group consisting of SEQ ID NO:

• 1 and SEQ ID NO:
• 2, a CDR2 selected from the group consisting of SEQ ID NO:
• 3, SEQ ID NO:
• 4, SEQ ID NO:
• 5, SEQ ID NO:
• 6, SEQ ID NO:
• 7, and SEQ ID NO:
• 8, and a CDR3 selected from the group consisting of SEQ ID NO:
• 9 and SEQ ID NO:
• 10, and a light chain variable domain with a CDR1 selected from the group consisting of SEQ ID NO:
• 11, SEQ ID NO:
• 12, and SEQ ID NO:
• 13, a CDR2 of SEQ ID NO:
• 14, and a CDR3 of SEQ ID NO:
• 15.